Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

INTRODUCTION: A proportion of patients receiving infliximab have antibodies toward infliximab (ATI), which are associated with increased risk of infusion reaction and reduced response to treatment. We studied the association of infliximab concentration at treatment initiation and development of ATI...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ducourau, Emilie, Mulleman, Denis, Paintaud, Gilles, Miow Lin, Delphine Chu, Lauféron, Francine, Ternant, David, Watier, Hervé, Goupille, Philippe
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3218920/
https://ncbi.nlm.nih.gov/pubmed/21708018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3386
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky